Position in ACLX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$23,841,453
+$11,011,920 QoQ
Shares Held
207,642
+5.5% QoQ
Ownership
0.355%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ACLX Over Time
Shares Held
Position Value (USD)
Derivatives in ACLX
reported options exposure · as of Sep 30, 2025CallValue
$303,770
CallShares
3,700
PutValue
$303,770
PutShares
3,700
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026BARCLAYS PLC holds $1,494,072,071 across 362 Biotechnology names. ACLX ranks #14 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
663,263 | $296,173,457 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
313,093 | $241,908,173 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
220,623 | $72,997,531 | |
| 4 | MRNA |
Moderna, Inc.
|
932,269 | $47,359,264 | |
| 5 | INSM |
INSMED Inc
|
275,731 | $45,087,531 | |
| 6 | ROIV |
Roivant Sciences Ltd.
|
1,415,848 | $39,218,988 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
383,179 | $37,264,156 | |
| 8 | TERN |
Terns Pharmaceuticals, Inc.
|
669,601 | $35,301,364 |
All Filings in ACLX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $23,841,453 | 207,642 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $12,829,533 | 196,772 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $8,838,557 | 107,656 | Shares | Sole | 2026-03-31 | |
| 2025-09-30 | $303,770 | 3,700 | Call | Sole | 2026-03-31 | |
| 2025-09-30 | $303,770 | 3,700 | Put | Sole | 2026-03-31 | |
| 2025-06-30 | $9,178,040 | 139,378 | Shares | Sole | 2026-02-27 | |
| 2025-03-31 | $5,093,118 | 77,639 | Shares | Sole | 2026-03-17 | |
| 2024-12-31 | $7,024,420 | 91,595 | Shares | Sole | 2026-03-19 | |
| 2024-09-30 | $1,670,200 | 20,000 | Put | Sole | 2026-03-31 | |
| 2024-09-30 | $1,670,200 | 20,000 | Call | Sole | 2026-03-31 | |
| 2024-09-30 | $7,125,240 | 85,322 | Shares | Sole | 2026-03-31 | |
| 2024-06-30 | $2,067,969 | 37,470 | Shares | Sole | 2026-03-23 | |
| 2024-03-31 | $2,761,343 | 39,703 | Shares | Sole | 2026-03-24 | |
| 2023-12-31 | $277,500 | 5,000 | Put | Sole | 2026-03-24 | |
| 2023-12-31 | $7,183,143 | 129,426 | Shares | Sole | 2026-03-24 | |
| 2023-09-30 | $3,092,389 | 86,187 | Shares | Sole | 2026-03-26 | |
| 2023-06-30 | $2,390,345 | 75,596 | Shares | Sole | 2026-03-27 | |
| 2023-03-31 | $1,821,302 | 59,114 | Shares | Sole | 2026-03-30 | |
| 2022-12-31 | $2,147,595 | 69,322 | Shares | Sole | 2026-03-30 | |
| 2022-09-30 | $1,108,124 | 59,037 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $8,913 | 493 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $20,735 | 1,479 | Shares | Sole | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||